- GlobeNewswire•21 days ago
Investigational new drug application on track to be submitted in May 2017 Manufacturing preparations in line to produce tablets, clinical batches produced Company anticipates filing new drug application ...
- GlobeNewswire•28 days ago
BRISBANE, Calif., March 30, 2017-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Cameron Durrant, ...
- GlobeNewswire•last month
BRISBANE, Calif., March 27, 2017-- KaloBios Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced today that it has ...
KBIO : Summary for KALOBIOS PHARMACEU COM USD0.001 - Yahoo Finance
KaloBios Pharmaceuticals, Inc. (KBIO)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||2.52 - 2.80|
|52 Week Range||1.90 - 5.21|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.92|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|